Document is current
Any future updates will be listed below
-
Authors
Edwards, Roger A.
Bonfanti, Gianluca
Grugni, Roberto
Manca, Luigi
Parsons, Bruce
Alexander, Joe
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct00156078 at ClinicalTrials.govnct00159679 at ClinicalTrials.govDocuments that mention this clinical trial
Predicting Responses to Pregabalin for Painful Diabetic Peripheral Neuropathy Based on Trajectory-Focused Patient Profiles Derived from the First 4 Weeks of Treatment
https://doi.org/10.1007/s12325-018-0780-3
nct00143156 at ClinicalTrials.govDocuments that mention this clinical trial
Predicting Responses to Pregabalin for Painful Diabetic Peripheral Neuropathy Based on Trajectory-Focused Patient Profiles Derived from the First 4 Weeks of Treatment
https://doi.org/10.1007/s12325-018-0780-3
nct00143156 at ClinicalTrials.govDocuments that mention this clinical trial
Predicting Responses to Pregabalin for Painful Diabetic Peripheral Neuropathy Based on Trajectory-Focused Patient Profiles Derived from the First 4 Weeks of Treatment
https://doi.org/10.1007/s12325-018-0780-3
nct00553475 at ClinicalTrials.govDocuments that mention this clinical trial
Predicting Responses to Pregabalin for Painful Diabetic Peripheral Neuropathy Based on Trajectory-Focused Patient Profiles Derived from the First 4 Weeks of Treatment
https://doi.org/10.1007/s12325-018-0780-3
Documents that mention this clinical trial
Predicting Responses to Pregabalin for Painful Diabetic Peripheral Neuropathy Based on Trajectory-Focused Patient Profiles Derived from the First 4 Weeks of Treatment
https://doi.org/10.1007/s12325-018-0780-3
-
Funding
Funding for this research was provided by:
Pfizer
- License Information
-
More Information
Article History
Received: 11 June 2018
First Online: 11 September 2018
